ProPhase Labs (NASDAQ: PRPH) reported Q3 EPS of $0.06, $0.13 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $24.2 million versus the consensus estimate of $18.42 million.

For earnings history and earnings-related data on ProPhase Labs (PRPH) click here.